PDS Biotechnology Corp (PDSB): debt financing — PDS Biotechnology issues $6M promissory note and warrant to YA II PN, redeems existing debentures

PDS Biotechnology Corp

Entered $6M promissory note at 10% interest, 12-month maturity, issued at $5.76M (96% of face).
Issued warrant for 2,158,274 shares at $1.1824, exercisable after 6 months for 5 years.
Redeeming existing Senior Secured Convertible Debentures at 103% of principal plus accrued interest on June 12, 2026.
Terminated prior sales agreement with B. Riley and H.C. Wainwright; entered new ATM with Yorkville Securities.
Note includes conversion rights upon default at discounted VWAP; warrant has cashless exercise option.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

PDS Biotechnology Corp incurred loan of $6,000,000 with YA II PN, LTD. at 10% per annum maturing twelve-month anniversary of the Closing Date.

Instrument: loan
Principal: $6,000,000
Counterparty: YA II PN, LTD.
Rate: 10% per annum
Maturity: twelve-month anniversary of the Closing Date
Event: incurrence

Exact text from the filing

Promissory Note will have an aggregate face value of $6,000,000 and will be issued on the Closing Date for a purchase price of $5,760,000. The Promissory Note will have a maturity date of the twelve-month anniversary of the Closing Date and an interest rate of 10% per annum

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PDS Biotechnology Corp entered into Securities Purchase Agreement with YA II PN, LTD. valued at $6,000,000 (effective 2026-04-30).

Action: entry
Agreement: equity purchase
Counterparty: YA II PN, LTD.
Value: $6,000,000
Effective: 2026-04-30

Exact text from the filing

On April 30, 2026 (the “ Effective Date ”), PDS Biotechnology Corporation, a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with YA II PN, LTD.

View on SEC.gov

Browse all debt financings →

PDS Biotechnology Corp filing history →

Source: SEC EDGAR

accession 0001140361-26-018464

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.